IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer

Yunxia Zhang,1,2 Jing Wang,2 Di Wu,1 Miao Li,1 Fenshu Zhao,1 Mulan Ren,2 Yunlong Cai,2 Jun Dou1 1Department of Pathogenic Biology and Immunology, School of Medicine, Southeast University, Nanjing, People’s Republic of China; 2Department of Gynecology & Obstetrics, Zhongda Hospital...

Full description

Bibliographic Details
Main Authors: Zhang Y, Wang J, Wu D, Li M, Zhao F, Ren M, Cai Y, Dou J
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/il-21-secreting-hucmscs-combined-with-mir-200c-inhibit-tumor-growth-an-peer-reviewed-article-OTT
id doaj-48c7e14c8c194d68b4fa6cf2eb6677da
record_format Article
spelling doaj-48c7e14c8c194d68b4fa6cf2eb6677da2020-11-25T00:59:35ZengDove Medical PressOncoTargets and Therapy1178-69302018-04-01Volume 112037205037669IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancerZhang YWang JWu DLi MZhao FRen MCai YDou JYunxia Zhang,1,2 Jing Wang,2 Di Wu,1 Miao Li,1 Fenshu Zhao,1 Mulan Ren,2 Yunlong Cai,2 Jun Dou1 1Department of Pathogenic Biology and Immunology, School of Medicine, Southeast University, Nanjing, People’s Republic of China; 2Department of Gynecology & Obstetrics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China Background: Epithelial ovarian cancer (EOC) with insidious characteristic manifests no symptoms in its early onset but most patients have advanced and distant cancer metastasis at diagnosis. Innovative early diagnosis and effective treatment of EOC are urgently needed. Methods: In the study, we developed a novel agent of IL-21-secreting human umbilical cord mesenchymal stem cells (hUCMSCs) combined with miR-200c to evaluate its effects on SKOV3 EOC in vitro and in vivo.Results: hUCMSCs-LV-IL-21 combined with miR-200c significantly inhibited the SKOV3 cell mobility and tumorigenesis compared with hUCMSCs-LV-IL-21, hUCMSCs- LV-vector, and hUCMSCs, respectively. These were reflected in decreasing the tumor sizes and elongating the tumor bearing nude mouse survival, accompanied with increasing the serum cytokine levels of IFN-γ, IL-21 and TNF-α as well as the splenocyte cytotoxicity. In addition, the expression of β-catenin, cyclin-D1, Gli1, Gli2, and ZEB1 was decreased but the E-cadherin expression was increased in tumor tissues of mice treated with hUCMSCs-LV-IL-21 plus miR-200c.Conclusion: We demonstrated that the synergistic effect of fighting SKOV3 EOC is attributable to repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in SKOV3 EOC. The findings may provide a new strategy for therapy of EOC. Keywords: epithelial ovarian cancer, umbilical cord mesenchymal stem cells, IL-21, miR-200c, Wnt/β-catenin signaling, epithelial–mesenchymal transitionhttps://www.dovepress.com/il-21-secreting-hucmscs-combined-with-mir-200c-inhibit-tumor-growth-an-peer-reviewed-article-OTTEpithelial ovarian cancerumbilical cord mesenchymal stem cellsIL-21miR-200cWnt/β-catenin signalingepithelial-mesenchymal transition
collection DOAJ
language English
format Article
sources DOAJ
author Zhang Y
Wang J
Wu D
Li M
Zhao F
Ren M
Cai Y
Dou J
spellingShingle Zhang Y
Wang J
Wu D
Li M
Zhao F
Ren M
Cai Y
Dou J
IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
OncoTargets and Therapy
Epithelial ovarian cancer
umbilical cord mesenchymal stem cells
IL-21
miR-200c
Wnt/β-catenin signaling
epithelial-mesenchymal transition
author_facet Zhang Y
Wang J
Wu D
Li M
Zhao F
Ren M
Cai Y
Dou J
author_sort Zhang Y
title IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
title_short IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
title_full IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
title_fullStr IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
title_full_unstemmed IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
title_sort il-21-secreting hucmscs combined with mir-200c inhibit tumor growth and metastasis via repression of wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2018-04-01
description Yunxia Zhang,1,2 Jing Wang,2 Di Wu,1 Miao Li,1 Fenshu Zhao,1 Mulan Ren,2 Yunlong Cai,2 Jun Dou1 1Department of Pathogenic Biology and Immunology, School of Medicine, Southeast University, Nanjing, People’s Republic of China; 2Department of Gynecology & Obstetrics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China Background: Epithelial ovarian cancer (EOC) with insidious characteristic manifests no symptoms in its early onset but most patients have advanced and distant cancer metastasis at diagnosis. Innovative early diagnosis and effective treatment of EOC are urgently needed. Methods: In the study, we developed a novel agent of IL-21-secreting human umbilical cord mesenchymal stem cells (hUCMSCs) combined with miR-200c to evaluate its effects on SKOV3 EOC in vitro and in vivo.Results: hUCMSCs-LV-IL-21 combined with miR-200c significantly inhibited the SKOV3 cell mobility and tumorigenesis compared with hUCMSCs-LV-IL-21, hUCMSCs- LV-vector, and hUCMSCs, respectively. These were reflected in decreasing the tumor sizes and elongating the tumor bearing nude mouse survival, accompanied with increasing the serum cytokine levels of IFN-γ, IL-21 and TNF-α as well as the splenocyte cytotoxicity. In addition, the expression of β-catenin, cyclin-D1, Gli1, Gli2, and ZEB1 was decreased but the E-cadherin expression was increased in tumor tissues of mice treated with hUCMSCs-LV-IL-21 plus miR-200c.Conclusion: We demonstrated that the synergistic effect of fighting SKOV3 EOC is attributable to repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in SKOV3 EOC. The findings may provide a new strategy for therapy of EOC. Keywords: epithelial ovarian cancer, umbilical cord mesenchymal stem cells, IL-21, miR-200c, Wnt/β-catenin signaling, epithelial–mesenchymal transition
topic Epithelial ovarian cancer
umbilical cord mesenchymal stem cells
IL-21
miR-200c
Wnt/β-catenin signaling
epithelial-mesenchymal transition
url https://www.dovepress.com/il-21-secreting-hucmscs-combined-with-mir-200c-inhibit-tumor-growth-an-peer-reviewed-article-OTT
work_keys_str_mv AT zhangy il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT wangj il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT wud il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT lim il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT zhaof il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT renm il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT caiy il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
AT douj il21secretinghucmscscombinedwithmir200cinhibittumorgrowthandmetastasisviarepressionofwntbetacateninsignalingandepithelialmesenchymaltransitioninepithelialovariancancer
_version_ 1725217548614500352